OPK – OPKO Health, Inc.
Float Short %
9.16
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.1
EPS Last/This Y
-0.28
EPS This/Next Y
0.01
Price
1.41
Target Price
3.62
Analyst Recom
1
Performance Q
11.02
Relative Volume
1.23
Beta
1.39
Ticker: OPK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | OPK | 1.365 | 0.10 | 0.02 | 74185 |
| 2025-07-28 | OPK | 1.355 | 0.10 | 0.01 | 74661 |
| 2025-07-29 | OPK | 1.355 | 0.10 | 0.00 | 74901 |
| 2025-07-30 | OPK | 1.35 | 0.10 | 0.01 | 74989 |
| 2025-07-31 | OPK | 1.275 | 0.10 | 0.01 | 75215 |
| 2025-08-01 | OPK | 1.185 | 0.09 | 0.02 | 75715 |
| 2025-08-04 | OPK | 1.27 | 0.09 | 0.31 | 76204 |
| 2025-08-05 | OPK | 1.27 | 0.09 | 0.00 | 76581 |
| 2025-08-06 | OPK | 1.275 | 0.09 | 0.02 | 76608 |
| 2025-08-07 | OPK | 1.235 | 0.09 | 0.00 | 76588 |
| 2025-08-08 | OPK | 1.245 | 0.09 | 0.00 | 76494 |
| 2025-08-11 | OPK | 1.3 | 0.09 | 0.00 | 76484 |
| 2025-08-12 | OPK | 1.325 | 0.09 | 0.00 | 76210 |
| 2025-08-13 | OPK | 1.35 | 0.09 | 0.02 | 76070 |
| 2025-08-14 | OPK | 1.355 | 0.09 | 0.02 | 76231 |
| 2025-08-15 | OPK | 1.365 | 0.09 | 0.05 | 76315 |
| 2025-08-18 | OPK | 1.395 | 0.09 | 0.05 | 74822 |
| 2025-08-19 | OPK | 1.365 | 0.09 | 0.75 | 75179 |
| 2025-08-20 | OPK | 1.385 | 0.09 | 0.31 | 75183 |
| 2025-08-21 | OPK | 1.385 | 0.09 | 0.00 | 75837 |
| 2025-08-22 | OPK | 1.405 | 0.09 | 0.30 | 75845 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | OPK | 1.37 | - | - | -0.37 |
| 2025-07-28 | OPK | 1.36 | - | - | -0.37 |
| 2025-07-29 | OPK | 1.35 | - | - | -0.37 |
| 2025-07-30 | OPK | 1.34 | - | - | -0.37 |
| 2025-07-31 | OPK | 1.28 | - | - | -0.37 |
| 2025-08-01 | OPK | 1.19 | - | - | -0.37 |
| 2025-08-04 | OPK | 1.27 | - | - | -0.37 |
| 2025-08-05 | OPK | 1.26 | - | - | -0.37 |
| 2025-08-06 | OPK | 1.27 | - | - | -0.37 |
| 2025-08-07 | OPK | 1.23 | - | - | -0.37 |
| 2025-08-08 | OPK | 1.25 | - | - | 0.00 |
| 2025-08-11 | OPK | 1.30 | - | - | 0.00 |
| 2025-08-12 | OPK | 1.33 | - | - | 0.00 |
| 2025-08-13 | OPK | 1.35 | - | - | 0.00 |
| 2025-08-14 | OPK | 1.36 | - | - | 0.00 |
| 2025-08-15 | OPK | 1.37 | - | - | 0.00 |
| 2025-08-18 | OPK | 1.39 | - | - | 0.00 |
| 2025-08-19 | OPK | 1.36 | - | - | -0.36 |
| 2025-08-20 | OPK | 1.39 | - | - | -0.36 |
| 2025-08-21 | OPK | 1.39 | - | - | -0.36 |
| 2025-08-22 | OPK | 1.41 | - | - | -0.36 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | OPK | 0.18 | 27.56 | 9.26 |
| 2025-07-28 | OPK | 0.18 | 26.62 | 9.26 |
| 2025-07-29 | OPK | 0.17 | 26.62 | 9.26 |
| 2025-07-30 | OPK | 0.17 | 26.62 | 9.26 |
| 2025-07-31 | OPK | 0.17 | 26.62 | 9.26 |
| 2025-08-01 | OPK | 0.17 | 26.62 | 9.26 |
| 2025-08-04 | OPK | 0.17 | 26.19 | 9.25 |
| 2025-08-05 | OPK | 0.17 | 26.19 | 9.25 |
| 2025-08-06 | OPK | 0.17 | 26.19 | 9.25 |
| 2025-08-07 | OPK | 0.17 | 26.19 | 9.25 |
| 2025-08-08 | OPK | 0.33 | 26.19 | 9.25 |
| 2025-08-11 | OPK | 0.33 | 26.37 | 9.25 |
| 2025-08-12 | OPK | 0.33 | 26.37 | 9.35 |
| 2025-08-13 | OPK | 0.33 | 26.37 | 9.35 |
| 2025-08-14 | OPK | 0.33 | 26.37 | 9.37 |
| 2025-08-15 | OPK | 0.33 | 26.37 | 9.37 |
| 2025-08-18 | OPK | 0.33 | 28.66 | 9.37 |
| 2025-08-19 | OPK | 0.33 | 28.66 | 9.16 |
| 2025-08-20 | OPK | 0.33 | 28.66 | 9.16 |
| 2025-08-21 | OPK | 0.33 | 28.66 | 9.16 |
| 2025-08-22 | OPK | 0.33 | 28.66 | 9.16 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.06
Avg. EPS Est. Next Quarter
-0.09
Insider Transactions
0.33
Institutional Transactions
28.66
Beta
1.39
Average Sales Estimate Current Quarter
166
Average Sales Estimate Next Quarter
168
Fair Value
Quality Score
46
Growth Score
23
Sentiment Score
53
Actual DrawDown %
77.5
Max Drawdown 5-Year %
-85.6
Target Price
3.62
P/E
Forward P/E
PEG
P/S
1.69
P/B
0.85
P/Free Cash Flow
EPS
-0.25
Average EPS Est. Cur. Y
-0.36
EPS Next Y. (Est.)
-0.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-26.68
Relative Volume
1.23
Return on Equity vs Sector %
-38.3
Return on Equity vs Industry %
-24.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Opko Health, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2997
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.
stock quote shares OPK – OPKO Health, Inc. Stock Price stock today
news today OPK – OPKO Health, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OPK – OPKO Health, Inc. yahoo finance google finance
stock history OPK – OPKO Health, Inc. invest stock market
stock prices OPK premarket after hours
ticker OPK fair value insiders trading